• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

F1000Res . Effect of elevated temperature on SARS-CoV-2 viability

tetano

Editor, Senior Moderator
F1000Res


. 2023 Jun 15;11:403.
doi: 10.12688/f1000research.110305.2. eCollection 2022. Effect of elevated temperature on SARS-CoV-2 viability

Harapan Harapan[SUP] 1 2 3 [/SUP], Edison Johar[SUP] 4 [/SUP], Chairin Nisa Maroef[SUP] 4 [/SUP], Ida Yus Sriyani[SUP] 4 [/SUP], Muhammad Iqhrammullah[SUP] 5 [/SUP], Hendrix Indra Kusuma[SUP] 3 6 [/SUP], Maimun Syukri[SUP] 7 [/SUP], Razali Razali[SUP] 8 [/SUP], Hamdani Hamdani[SUP] 8 [/SUP], Rudi Kurniawan[SUP] 8 [/SUP], Irwansyah Irwansyah[SUP] 8 [/SUP], Sarwo Edhy Sofyan[SUP] 8 [/SUP], Khin Saw Myint[SUP] 4 [/SUP], T M Indra Mahlia[SUP] 9 [/SUP], Samsul Rizal[SUP] 8 [/SUP]



Affiliations
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide disruption of global health putting healthcare workers at high risk. To reduce the transmission of SARS-CoV-2, in particular during treating the patients, our team aims to develop an optimized isolation chamber. The present study was conducted to evaluate the role of temperature elevation against SARS-CoV-2 viability, where the information would be used to build the isolation chamber. 0.6 mL of the Indonesian isolate of SARS-CoV-2 strain 20201012747 (approximately 10 [SUP]13[/SUP] PFU/mL) was incubated for one hour with a variation of temperatures: 25, 30, 35, 40, 45, 50, 55, 60, and 65°C in digital block heater as well as at room temperature (21-23°C) before used to infect Vero E6 cells. The viability was determined using a plaque assay. Our data found a significant reduction of the viral viability from 10 [SUP]13[/SUP] PFU/mL to 10 [SUP]9[/SUP] PFU/mL after the room temperature was increase to 40°C. Further elevation revealed that 55°C and above resulted in the total elimination of the viral viability. Increasing the temperature 40°C to reduce the SARS-CoV-2 survival could create mild hyperthermia conditions in a patient which could act as a thermotherapy. In addition, according to our findings, thermal sterilization of the vacant isolation chamber could be conducted by increasing the temperature to 55°C. In conclusion, elevating the temperature of the isolation chamber could be one of the main variables for developing an optimized isolation chamber for COVID-19 patients.

Keywords: COVID-19; Isolation chamber; SARS-CoV-2; Temperature; Transmission.

 
Back
Top Bottom